Abstract
In an article in this issue of Clinical Cancer Research , Yasui et al. ([1][1]) suggest that cyclin D1 may play a role in maintaining vascular endothelial growth factor (VEGF) expression and that antisense cyclin D1 could be useful for targeting cancer cells and tumor vessels. Tumor growth and
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
